Antiproliferative effects of PACAP and VIP in serum-starved glioma cells

Journal of Molecular Neuroscience

Volumn 51, Issue 2, 2013, Pages 503-513

  D'Amico, Agata Grazia ^a   Scuderi, Soraya ^a   Saccone, Salvatore ^a   Castorina, Alessandro ^a   Drago, Filippo ^a   D'Agata, Velia ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Calorie restriction; Glioma cells; Pituitary adenylate cyclase activating polypeptide; Vasoactive intestinal peptide

Indexed keywords

BETA TUBULIN; CASPASE 3; CYCLIN D1; DNA POLYMERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; NESTIN; PROTEIN BCL 2; PROTEIN P53; RIBOSOMAL PROTEIN S18; RIBOSOME PROTEIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CALORIC RESTRICTION; CANCER PROGNOSIS; CELL ASSAY; CELL CYCLE PROGRESSION; CELL DEATH; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; CELL SUBPOPULATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; GENE AMPLIFICATION; GLIOMA CELL; IMMUNOBLOTTING; IMMUNOLOCALIZATION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RIBOSOME SUBUNIT; TUMOR CELL CULTURE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; CYCLIN D1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; NESTIN; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84885179802     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0076-7     Document Type: Article

References (50)

1. Almqvist PM, Mah R, Lendahl U, Jacobsson B, Hendson G (2002) Immunohistochemical detection of nestin in pediatric brain tumors. J Histochem Cytochem 50:147-158
2. Arimura A (1998) Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301-331
3. Bastien-Dionne PO, Valenti L, Kon N, Gu W, Buteau J (2011) Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic beta-cell mass expansion. Diabetes 60:3217-3222
4. Bonnin JM, Rubinstein LJ (1984) Immunohistochemistry of central nervous system tumors. Its contributions to neurosurgical diagnosis. J Neurosurg 60:1121-1133
5. Castorina A, Giunta S, Scuderi S, D'Agata V (2012) Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells. J Mol Neurosci 48:674-683
6. Castorina A, Leggio GM, Giunta S et al (2011) Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains. Neurochem Res 36:426-434
7. Castorina A, Tiralongoa A, Giunta S, Carnazza ML, Rasic G, D'Agata V (2008) PACAP and VIP prevent apoptosis in schwannoma cells. Brain Res 1241:29-35
8. Chumbalkar VC, Subhashini C, Dhople VM et al (2005) Differential protein expression in human gliomas and molecular insights. Proteomics 5:1167-1177
9. Dahlstrand J, Collins VP, Lendahl U (1992) Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52:5334-5341
10. D'Amico AG, Castorina A, Leggio GM, Drago F, D'Agata V (2013) Hippocampal neurofibromin and amyloid precursor protein expression in dopamine D(3) receptor knock-out mice following passive avoidance conditioning. Neurochem Res 38:564-572
11. Dickson L, Finlayson K (2009) VPAC and PAC receptors: from ligands to function. Pharmacol Ther 121:294-316
12. Dufes C, Alleaume C, Montoni A, Olivier JC, Muller JM (2003) Effects of the vasoactive intestinal peptide (VIP) and relate peptides on glioblastoma cell growth in vitro. J Mol Neurosci 21:97-108
13. Ehrmann J, Kolár Z, Mokry J (2005) Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours. J Clin Pathol 58:222-223
14. Farini D, Puglianiello A, Mammi C, Siracusa G, Moretti C (2003) Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: short- and long-term exposure affect proliferation and neuroendocrine differentiation. Endocrinology 144:1631-1643
15. Fontana L, Klein S (2007) Aging, adiposity, and calorie restriction. JAMA 297:986-994
16. Godlewski J, Łakomy IM (2010) Changes in vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide and neuropeptide Y-ergic structures of the enteric nervous system in the carcinoma of the human large intestine. Folia Histochem Cytobiol 48:208-216
17. Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T (2005) Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-sensitive form of VPAC1 receptor. J Neuroimmunol 158:94-105
18. Gozes I, Fridkinb M, Hill JM, Brenneman DE (1999) Pharmaceutical VIP: prospects and problems. Curr Med Chem 6:1019-1034
19. Harhaji-Trajkovic L, Arsikin, Kravic-Stevovic T, Petricevic S, Tovilovic G, Pantovic A, Zogovic N, Ristic B, Janjetovic K, Bumbasirevic V, Trajkovic V (2012) Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation. Pharm Res 29:2249-2263
20. Héraud C, Hilairet S, Muller JM, Leterrier JF, Chadéneau C (2004) Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5y cells is associated with regulated expression of cytoskeleton mRNAs and proteins. J Neurosci Res 75:320-329
21. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC (2003) Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54:131-152
22. Jamen F, Bouschet T, Laden JC, Bockaert J, Brabet P (2002) Up-regulation of the PACAP type-1 receptor (PAC1) promoter by neurotrophins in rat PC12 cells and mouse cerebellar granule cells via the Ras/mitogen-activated protein kinase cascade. J Neurochem 82:1199-1207
23. Jaworski DM (2000) Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and response to acute intracranial injury. Cell Tissue Res 300:219-230
24. Kaushik S, Rodriguez-Navarro JA, Arias E et al (2011) Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab 14:173-183
25. Kitai R, Horita R, Sato K et al (2010) Nestin expression in astrocytic tumors delineates tumor infiltration. Brain Tumor Pathol 27:17-21
26. Krzemiński P, Supłat D, Czajkowski R, Pomorski P, Barańska J (2007) Expression and functional characterization of P2Y1 and P2Y12 nucleotide receptors in long-term serum-deprived glioma C6 cells. FEBS J 274:1970-1982
27. Le SV, Yamaguchi DJ, McArdle CA, Tachiki K, Pisegna JR, Germano P (2002) PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells. Regul Pept 109:115-125
28. Lelièvre V, Meunier AC, Caigneaux E, Falcon J, Muller JM (1998a) Differential expression and function of PACAP and VIP receptors in four human colonic adenocarcinoma cell lines. Cell Signal 10:13-26
29. Lelièvre V, Pineau N, Du J et al (1998b) Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. J Biol Chem 273:19685-19690
30. Longo VD, Fontana L (2010) Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci 31:89-98
31. Lu WJ, Lan F, He Q et al (2011) Inducible expression of stem cell associated intermediate filament reveals an important role in glioblastoma carcinogenesis. Int J Cancer 128:343-351
32. Moody TW, Hill JM, Jensen RT (2003) VIP as a trophic factor in the CNS and cancer cells. Peptides 24:163-177
33. Njaine B, Martins RA, Santiago MF, Linden R, Silveira MS (2010) Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1. Eur J Neurosci 32:311-321
34. Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA (2000) Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res 60:3105-3112
35. Rutka JT, Ivanchuk S, Mondal S et al (1999) Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells. Int J Dev Neurosci 17:503-515
36. Sampath P, Weaver CE, Sungarian A, Cortez S, Alderson L, Stopa EG (2004) Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma. Cancer Control 11:174-180
37. Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S (2004) Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastc human tissues with subtype-specific antibodies. Clin Cancer Res 10:8235-8242
38. Sell C (2003) Caloric restriction and insulin-like growth factors in aging and cancer. Horm Metab Res 35:705-711
39. Sokolowska P, Nowak JZ (2006) Cyclic AMP formation in C6 glioma cells: effect of PACAP and VIP in early and late passages. Ann N Y Acad Sci 1070:566-569
40. Sokolowska P, Nowak JZ (2008) Effects of PACAP and VIP on cAMP-generating system and proliferation of C6 glioma cells. J Mol Neurosci 36:286-291
41. Sugawara K, Kurihara H, Negishi M et al (2002) Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 82:345-351
42. Szanto Z, Sarszegi Z, Reglodi D et al (2012) PACAP immunoreactivity in human malignant tumor samples and cardiac diseases. J Mol Neurosci 48(3):667-673
43. Tohyama T, Lee VM, Rorke LB, Marvin M, McKay RD, Trojanowski JQ (1992) Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 66:303-313
44. Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283-357
45. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52:269-324
46. Vertongen P, Camby I, Darro F, Kiss R, Robberech P (1996) VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP 2 receptor. Neuropeptides 30:491-496
47. Veselska R, Kuglik P, Cejpek P et al (2006) Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer 6:32
48. Waschek JA (2002) Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev Neurosci 24:14-23
49. You H, Kim YI, Im SY et al (2005) Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma. J Neurooncol 74:1-8
50. Zhou R, Skalli O (2000) TGF-alpha differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: correlation with cell shape and motility. Exp Cell Res 254:269-278